(Q33373912)

English

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

thrombocytopenia

1 reference

based on heuristic

inferred from title

thrombotic thrombocytopenic purpura

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Marie Scully

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Hannah Cohen

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jamie Cavenagh

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sylvia Benjamin

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Richard Starke

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sally Killick

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ian Mackie

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Samuel J Machin

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

136

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

451-461

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Responsiveness of thrombotic thrombocytopenic purpura to rituximab and cyclophosphamide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Rituximab therapy for refractory thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Rituximab in patients with refractory thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06448.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2006.06448.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33373912&oldid=2045219755"